EBR Systems Inc (ASX: EBR) - Share Price
Current share price for EBR : $0.435 0.005 (1.14%)+
EBR Systems Inc (EBR), an ASX-listed company, is dedicated to treatment of cardiac rhythm disease by providing physiologically effective stimulation through wireless cardiac pacing. The patented proprietary Wireless Stimulation Endocardially (WiSE) technology was developed to eliminate the need for cardiac pacing leads, historically the source of complications, effectiveness and reliability issues in cardiac rhythm disease management.
EBR General Information +
| ASX Code | EBR |
| Website | N/A |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 327 |
| EBR Share Price | $0.435 |
| Day High | $0.450 |
| Day Low | $0.430 |
| Last Close | $0.440 |
| EBR Share Price Movement | $0.01 ( 1.14% ) |
Prices as at 16:40, 3 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
EBR Systems Inc (EBR) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from EBR Systems Inc (EBR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
EBR Systems Inc (EBR) price-sensitive announcements
EBR - Retail Entitlement Offer Opens
EBR Systems, Inc. has announced the opening of its Retail Entitlement Offer on June 11, 20
EBR Systems Inc (EBR)
11 Jun 2026 | 9:59 AM
11 Jun 2026 | 9:59 AM
EBR - Successful Completion of Institutional Offer
EBR Systems, Inc., a developer of wireless cardiac pacing devices, announced the successfu
EBR Systems Inc (EBR)
5 Jun 2026 | 9:25 AM
5 Jun 2026 | 9:25 AM
EBR - EBR to Raise A$150m via Fully Underwritten Capital Raising
EBR Systems Inc, based in Sunnyvale, California, announced a fully underwritten capital ra
EBR Systems Inc (EBR)
4 Jun 2026 | 11:41 AM
4 Jun 2026 | 11:41 AM
EBR - Trading Halt
On June 4, 2026, EBR Systems, Inc. requested a trading halt on their securities listed on
EBR Systems Inc (EBR)
4 Jun 2026 | 10:06 AM
4 Jun 2026 | 10:06 AM
EBR Systems Inc (EBR) Recent ASX Announcements
EBR Financial Summary
| Year to Dec | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2027F | C2 | -$18.70 | -5.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2026F | C2 | -$19.80 | 21.10% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$72.85 | -$16.30 | -13.50% | 0.00 | 0.00 | 0.00% | 0.0% |
EBR Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 A | 2026 F | 2027 F | 2025 A | 2026 F | 2027 F | 2025 A | 2026 F | 2027 F | ||
| Cochlear Limited (COH) | $7,871M | 0.0171 | -0.1883 | 0.0862 | 20.1110 | 24.7761 | 22.8108 | 3.57% | 2.88% | 3.07% |
| EBR Systems Inc (EBR) | $331M | -0.1354 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $18,782M | 0.1388 | 0.1340 | 0.1883 | 48.3593 | 42.6457 | 35.8882 | 1.36% | 1.45% | 1.64% |
| ResMed Inc. (RMD) | $16,747M | 0.3087 | 9.7641 | 0.0805 | 201.6506 | 18.7336 | 17.3378 | 1.14% | 1.20% | 1.26% |
EBR Directors
| Name | Position | Start Date |
|---|---|---|
| Mr John Graham McCutcheon | Chief Executive Officer, President, Executive Director | 17 Jun 2019 |
| Mr Allan Roger Will | Executive Chairman, Executive Director | 9 May 2003 |
| Dr Christopher Dean Nave | Non-Executive Director | 30 Oct 2017 |
| Ms Karen Ruth Drexler | Non-Executive Director | 1 Oct 2021 |
| Dr Bronwyn Joy Evans | Non-Executive Director | 1 Oct 2021 |
| Dr David Mark Steinhaus | Non-Executive Director | 1 Oct 2021 |
| Mr Trevor John Moody | Non-Executive Director | 30 Oct 2017 |
EBR Systems Inc (EBR) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 15 Jun 2026 | EVANS, Bronwyn | Buy | Indirect Shares | 300,000 | $0.383 | $114,876.230 |
| 24 Mar 2026 | MCCUTCHEON, John | Exercise | Options | 109,100 | $0.550 | $60,005.000 |
| 24 Mar 2026 | MCCUTCHEON, John | Buy | Direct Shares | 109,100 | $0.550 | $60,005.000 |
See all changes in directors' interest & trades for EBR Systems Inc (EBR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
EBR Management
| Name | Position |
|---|---|
| Eric Strandberg | Chief Commercial Officer |
| Andrew Shute | Chief Corporate Development Officer |
| Gary William Doherty | Chief Financial Officer |
| Spencer H. Kubo | Chief Medical Officer |
| Michael Hendricksen | Chief Operating Officer |
| Pharoah Garma | Chief Regulatory Officer |
| N. Parker Willis | Chief Technology Officer |
| Zheng(Kobe) Li | Company Secretary |
| Philip Hale Oettinger | Unites States Company Secretary |
EBR Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EBR Systems Inc (EBR). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 42,795,906 (9.50%) | Host Plus Pty Limited |
| 41,056,191 (9.11%) | Carnegie Group |
| 33,509,252 (7.44%) | H.E.S.T. Australia Limited |
| 26,728,931 (5.93%) | Split Rock Partners, LP |
EBR Calendar of Events
| Date | Event |
|---|---|
| 11 May 2027 | Report (Quarterly) |
| 30 March 2027 | Report (Annual) |
| 26 March 2027 | Report (Annual) |
| 12 November 2026 | Report (Quarterly) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
